Identification of a pivotal endocytosis motif in c-Met and selective modulation of HGF-dependent aggressiveness of cancer using the 16-mer endocytic peptide

Oncogene

Volumn 32, Issue 8, 2013, Pages 1018-1029

  Cho, K W ^a   Park, J H ^a,b   Park, C W ^a   Lee, D ^a   Lee, E ^a   Kim, D J ^a   Kim, K J ^a   Yoon, S H ^a   Park, Y ^a   Kim, E ^a,b   Cho, S ^a   Jang, S ^a   Park, B C ^a   Chi, S W ^a   Yoo, S H ^c   Jang, M H ^c   Kim, H N ^c   Jo, K ^d   Park, Y W ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Chungnam National University   (South Korea)

^c A and R Therapeutics   (South Korea)

^d National Cancer Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTENNAPEDIA PROTEIN; BETA ADAPTIN; CAVEOLIN 1; CHIMERIC PROTEIN; INTERLEUKIN 2 RECEPTOR ALPHA; SCATTER FACTOR RECEPTOR;

AGGRESSIVENESS; ARTICLE; CANCER CELL; CANCER GROWTH; CELL MIGRATION; CELL TRANSFER; CONTROLLED STUDY; ENDOCYTOSIS; HUMAN; HUMAN CELL; INTERNALIZATION; PRIORITY JOURNAL; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

AMINO ACID MOTIFS; ANIMALS; CELL LINE, TUMOR; ENDOCYTOSIS; HEPATOCYTE GROWTH FACTOR; HUMANS; MICE; NEOPLASMS; PEPTIDES; PROTO-ONCOGENE PROTEINS C-MET; SIGNAL TRANSDUCTION;

EID: 84874784160     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2012.122     Document Type: Article

References (52)

1. Polo S, Di Fiore PP. Endocytosis conducts the cell signaling orchestra. Cell 2006; 124: 897-900.
2. Kermorgant S, Zicha D, Parker PJ. PKC controls HGF-dependent c-Met traffic, signalling and cell migration. EMBO J 2004; 23: 3721-3734.
3. Kermorgant S, Zicha D, Parker PJ. Protein kinase C controls microtubule-based traffic but not proteasomal degradation of c-Met. J Biol Chem 2003; 278: 28921-28929.
4. Petrelli A, Gilestro GF, Lanzardo S, Comoglio PM, Migone N, Giordano S. The endophilin-CIN85-Cbl complex mediates ligand-dependent downregulation of c-Met. Nature 2002; 416: 187-190.
5. Li N, Lorinczi M, Ireton K, Elferink LA. Specific Grb2-mediated interactions regulate clathrin-dependent endocytosis of the cMet-tyrosine kinase. J Biol Chem 2007; 282: 16764-16775.
6. Singleton PA, Salgia R, Moreno-Vinasco L, Moitra J, Sammani S, Mirzapoiazova T et al. CD44 regulates hepatocyte growth factor-mediated vascular integrity. Role of c-Met, Tiam1/Rac1, dynamin 2, and cortactin. J Biol Chem 2007; 282: 30643-30657.
7. Kamei T, Matozaki T, Sakisaka T, Kodama A, Yokoyama S, Peng YF, et al. Coendocytosis of cadherin and c-Met coupled to disruption of cell-cell adhesion in MDCK cells-regulation by Rho, Rac and Rab small G proteins. Oncogene 1999; 18: 6776-6784.
8. Peschard P, Fournier TM, Lamorte L, Naujokas MA, Band H, Langdon WY et al. Mutation of the c-Cbl TKB domain binding site on the Met receptor tyrosine kinase converts it into a transforming protein. Mol Cell 2001; 8: 995-1004.
9. Abella JV, Peschard P, Naujokas MA, Lin T, Saucier C, Urbe S, et al. Met/Hepatocyte growth factor receptor ubiquitination suppresses transformation and is required for Hrs phosphorylation. Mol Cell Biol 2005; 25: 9632-9645.
10. Mettlen M, Stoeber M, Loerke D, Antonescu CN, Danuser G, Schmid SL. Endocytic accessory proteins are functionally distinguished by their differential effects on the maturation of clathrin-coated pits. Mol Biol Cell 2009; 20: 3251-3260.
11. Le Roy C, Wrana JL. Clathrin- and non-clathrin-mediated endocytic regulation of cell signalling. Nat Rev Mol Cell Biol 2005; 6: 112-126.
12. Schmidt U, Briese S, Leicht K, Schurmann A, Joost HG, Al-Hasani H. Endocytosis of the glucose transporter GLUT8 is mediated by interaction of a dileucine motif with the beta2-adaptin subunit of the AP-2 adaptor complex. J Cell Sci 2006; 119: 2321-2331.
13. Doray B, Lee I, Knisely J, Bu G, Kornfeld S. The gamma/sigma1 and alpha/sigma2 hemicomplexes of clathrin adaptors AP-1 and AP-2 harbor the dileucine recognition site. Mol Biol Cell 2007; 18: 1887-1896.
14. Byland R, Vance PJ, Hoxie JA, Marsh M. A conserved dileucine motif mediates clathrin and AP-2-dependent endocytosis of the HIV-1 envelope protein. Mol Biol Cell 2007; 18: 414-425.
15. Kelly BT, McCoy AJ, Spate K, Miller SE, Evans PR, Honing S, et al. A structural explanation for the binding of endocytic dileucine motifs by the AP2 complex. Nature 2008; 456: 976-979.
16. Green M, Loewenstein PM. Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein. Cell 1988; 55: 1179-1188.
17. Liu GS, Cohen MV, Mochly-Rosen D, Downey JM. Protein kinase C-epsilon is responsible for the protection of preconditioning in rabbit cardiomyocytes. J Mol Cell Cardiol 1999; 31: 1937-1948.
18. Derossi D, Calvet S, Trembleau A, Brunissen A, Chassaing G, Prochiantz A. Cell internalization of the third helix of the Antennapedia homeodomain is receptorindependent. J Biol Chem 1996; 271: 18188-18193.
19. Lindgren M, Gallet X, Soomets U, Hallbrink M, Brakenhielm E, Pooga M, et al. Translocation properties of novel cell penetrating transportan and penetratin analogues. Bioconjug Chem 2000; 11: 619-626.
20. Joliot A, Pernelle C, Deagostini-Bazin H, Prochiantz A. Antennapedia homeobox peptide regulates neural morphogenesis. Proc Natl Acad Sci USA 1991; 88: 1864-1868.
21. Lindsay MA. Peptide-mediated cell delivery: application in protein target validation. Curr Opin Pharmacol 2002; 2: 587-594.
22. Garippa RJ, Johnson A, Park J, Petrush RL, McGraw TE. The carboxyl terminus of GLUT4 contains a serine-leucine-leucine sequence that functions as a potent internalization motif in Chinese hamster ovary cells. J Biol Chem 1996; 271: 20660-20668.
23. Craven SE, Bredt DS. Synaptic targeting of the postsynaptic density protein PSD-95 mediated by a tyrosine-based trafficking signal. J Biol Chem 2000; 275: 20045-20051.
24. Clark SG, Shurland DL, Meyerowitz EM, Bargmann CI, van der Bliek AM. A dynamin GTPase mutation causes a rapid and reversible temperature-inducible locomotion defect in C. elegans. Proc Natl Acad Sci USA 1997; 94: 10438-10443.
25. Kermorgant S, Parker PJ. Receptor trafficking controls weak signal delivery: a strategy used by c-Met for STAT3 nuclear accumulation. J Cell Biol 2008; 182: 855-863.
26. Derossi D, Joliot AH, Chassaing G, Prochiantz A. The third helix of the Antennapedia homeodomain translocates through biological membranes. J Biol Chem 1994; 269: 10444-10450.
27. Stein A, Aloy P. Contextual specificity in peptide-mediated protein interactions. PLoS One 2008; 3: e2524.
28. Ball LJ, Kuhne R, Hoffmann B, Hafner A, Schmieder P, Volkmer-Engert R, et al. Dual epitope recognition by the VASP EVH1 domain modulates polyproline ligand specificity and binding affinity. EMBO J 2000; 19: 4903-4914.
29. Ferracini R, Longati P, Naldini L, Vigna E, Comoglio PM. Identification of the major autophosphorylation site of the Met/hepatocyte growth factor receptor tyrosine kinase. J Biol Chem 1991; 266: 19558-19564.
30. Tong J, Taylor P, Peterman SM, Prakash A, Moran MF. Epidermal growth factor receptor phosphorylation sites Ser991 and Tyr998 are implicated in the regulation of receptor endocytosis and phosphorylations at Ser1039 and Thr1041. Mol Cell Proteomics 2009; 8: 2131-2144.
31. Rothenberger S, Iacopetta BJ, Kuhn LC. Endocytosis of the transferrin receptor requires the cytoplasmic domain but not its phosphorylation site. Cell 1987; 49: 423-431.
32. Cantiani L, Manara MC, Zucchini C, De Sanctis P, Zuntini M, Valvassori L, et al. Caveolin-1 reduces osteosarcoma metastases by inhibiting c-Src activity and met signaling. Cancer Res 2007; 67: 7675-7685.
33. Schroeder B, Weller SG, Chen J, Billadeau D, McNiven MA. A Dyn2-CIN85 complex mediates degradative traffic of the EGFR by regulation of late endosomal budding. EMBO J 2010; 29: 3039-3053.
34. Kirisits A, Pils D, Krainer M. Epidermal growth factor receptor degradation: an alternative view of oncogenic pathways. Int J Biochem Cell Biol 2007; 39: 2173-2182.
35. Sorkin A, von Zastrow M. Endocytosis and signalling: intertwining molecular networks. Nat Rev Mol Cell Biol 2009; 10: 609-622.
36. Liu ZX, Yu CF, Nickel C, Thomas S, Cantley LG. Hepatocyte growth factor induces ERK-dependent paxillin phosphorylation and regulates paxillin-focal adhesion kinase association. J Biol Chem 2002; 277: 10452-10458.
37. Gomes DA, Rodrigues MA, Leite MF, Gomez MV, Varnai P, Balla T, et al. c-Met must translocate to the nucleus to initiate calcium signals. J Biol Chem 2008; 283: 4344-4351.
38. Joffre C, Barrow R, Menard L, Calleja V, Hart IR, Kermorgant S. A direct role for Met endocytosis in tumorigenesis. Nat Cell Biol 2011; 13: 827-837.
39. Craig HM, Reddy TR, Riggs NL, Dao PP, Guatelli JC. Interactions of HIV-1 nef with the mu subunits of adaptor protein complexes 1, 2, and 3: role of the dileucinebased sorting motif. Virology 2000; 271: 9-17.
40. Diviani D, Lattion AL, Abuin L, Staub O, Cotecchia S. The adaptor complex 2 directly interacts with the alpha 1b-adrenergic receptor and plays a role in receptor endocytosis. J Biol Chem 2003; 278: 19331-19340.
41. Shewan AM, Marsh BJ, Melvin DR, Martin S, Gould GW, James DE. The cytosolic C-terminus of the glucose transporter GLUT4 contains an acidic cluster endosomal targeting motif distal to the dileucine signal. Biochem J 2000; 350 (Pt 1): 99-107.
42. Flessner LB, Moley KH. Similar [DE]XXXL[LI] motifs differentially target GLUT8 and GLUT12 in chinese hamster ovary cells. Traffic 2009; 10: 324-333.
43. Wang W, Loh HH, Law PY. The intracellular trafficking of opioid receptors directed by carboxyl tail and a di-leucine motif in Neuro2A cells. J Biol Chem 2003; 278: 36848-36858.
44. Garnier J, Gibrat JF, Robson B. GOR method for predicting protein secondary structure from amino acid sequence. Methods Enzymol 1996; 266: 540-553.
45. Lindberg M, Biverstahl H, Graslund A, Maler L. Structure and positioning comparison of two variants of penetratin in two different membrane mimicking systems by NMR. Eur J Biochem 2003; 270: 3055-3063.
46. Czajlik A, Mesko E, Penke B, Perczel A. Investigation of penetratin peptides. Part 1. The environment dependent conformational properties of penetratin and two of its derivatives. J Pept Sci 2002; 8: 151-171.
47. Branco MC, Sigano DM, Schneider JP. Materials from peptide assembly: towards the treatment of cancer and transmittable disease. Curr Opin Chem Biol 2011; 15: 427-434.
48. Rosca EV, Koskimaki JE, Rivera CG, Pandey NB, Tamiz AP, Popel AS. Antiangiogenic peptides for cancer therapeutics. Curr Pharm Biotechnol 2011; 12: 1101-1116.
49. Shojaei F, Lee JH, Simmons BH, Wong A, Esparza CO, Plumlee PA, et al. HGF/c-Met acts as an alternative angiogenic pathway in sunitinib-resistant tumors. Cancer Res 2010; 70: 10090-10100.
50. Grepin R, Pages G. Molecular mechanisms of resistance to tumour anti-angiogenic strategies. J Oncol 2010; 2010: 835680.
51. Al-Hasani H, Yver DR, Cushman SW. Overexpression of the glucose transporter GLUT4 in adipose cells interferes with insulin-stimulated translocation. FEBS Lett 1999; 460: 338-342.
52. Lisinski I, Schurmann A, Joost HG, Cushman SW, Al-Hasani H. Targeting of GLUT6 (formerly GLUT9) and GLUT8 in rat adipose cells. Biochem J 2001; 358: 517-522.